KIR2DS4 and hepatocellular carcinoma: In contrast, the absence of both the KIR3DL1 and KIR2DS4 genes (Tel-2DS4 (8), Table 3) was less frequent in HCC patients than in CHC patients (1.7% versus 8.8%, p = 0.02, Fig. 3F).